At Informa Connect’s Copay, Reimbursement and Access Congress, Carl Schmid discusses the litigation filed by HIV+Hep, the DLC, and the DPAC in the U.S. District Court for DC challenging a federal rule that allows health insurers to avoid counting the value of drug manufacturer copay assistance toward patients’ out-of-pocket cost obligations in violation of the ACA definition of and regulations for cost-sharing.
![Ensuring copay assistance counts for patients: Litigation update](https://hivhep.org/wp-content/uploads/2022/10/Ensuring-Copay-Assistance-Counts-for-Patients-Litigation-Update-10.14.22.png)